XML 45 R30.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Note 9 - Stock-based Compensation (Tables)
12 Months Ended
Mar. 31, 2024
Notes Tables  
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
  

2024

  

2023

 
  

Weighted-

      

Weighted-

     
  

Average

  

Number of

  

Average

  

Number of

 
  

Exercise

  

Options

  

Exercise

  

Options

 
  

Price

  

Outstanding

  

Price

  

Outstanding

 

Outstanding at Beginning of Period

 $7.32   735,500  $7.39   635,500 

Granted

  5.20   170,000   6.54   120,000 

Exercised

  -   -   4.92   (20,000)

Expired

  6.14   (10,000)  -   - 

Outstanding at End of Period

  6.93   895,500   7.32   735,500 

Exercisable at End of Period

  7.41   665,500   7.42   499,000 
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
  

Fiscal Year Ended

 
  

March 31, 2024

  

April 2, 2023

 

Number of options issued

  40,000   10,000   120,000   120,000 

Grant date

 

March 26, 2024

  

November 14, 2023

  

June 21, 2023

  

June 7, 2022

 

Dividend yield

  6.07%  7.60%  6.08%  4.89%

Expected volatility

  20.00%  20.00%  25.00%  30.00%

Risk free interest rate

  4.38%  4.56%  4.29%  2.95%

Contractual term (years)

  10.00   10.00   10.00   10.00 

Expected term (years)

  3.00   3.00   3.00   4.00 

Forfeiture rate

  5.00%  5.00%  5.00%  5.00%

Exercise price (grant-date closing price) per option

 $5.27  $4.21  $5.26  $6.54 

Fair value per option

 $0.32  $0.20  $0.46  $0.90 
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
  

Fiscal Year Ended March 31, 2024

 
  

Cost of

  

Marketing &

     
  

Products

  

Administrative

  

Total

 

Options Granted in Fiscal Year

 

Sold

  

Expenses

  

Expense

 

2022

 $10  $21  $31 

2023

  22   32   54 

2024

  9   11   20 
             

Total stock option compensation

 $41  $64  $105 
  

Fiscal Year Ended April 2, 2023

 
  

Cost of

  

Marketing &

     
  

Products

  

Administrative

  

Total

 

Options Granted in Fiscal Year

 

Sold

  

Expenses

  

Expense

 

2021

 $4  $41  $45 

2022

  40   86   126 

2023

  17   24   41 
             

Total stock option compensation

 $61  $151  $212 

Stock Granted in Fiscal Year

 

2024

  

2023

 

2021

 $-  $48 

2022

  185   576 

2023

  195   269 

2024

  278   - 
         

Total stock grant compensation

 $658  $893 
Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]
            

Weighted-

      

Weighted-

 
        

Weighted-

  

Avg. Exercise

      

Avg. Exercise

 
    

Number

  

Avg. Remaining

  

Price of

  

Number

  

Price of

 

Exercise

  

of Options

  

Contractual

  

Options

  

of Options

  

Options

 

Price

  

Outstanding

  

Life in Years

  

Outstanding

  

Exercisable

  

Exercisable

 
$4.00-4.99   105,000   6.09  $4.78   95,000  $4.84 
$5.00-5.99   180,000   8.84  $5.33   20,000  $5.90 
$6.00-6.99   120,000   8.19  $6.54   60,000  $6.54 
$7.00-7.99   365,500   5.22  $7.74   365,500  $7.74 
$8.00-8.99   55,000   1.20  $8.38   55,000  $8.38 
$9.00-9.99   70,000   2.19  $9.60   70,000  $9.60 
     895,500   5.96  $6.93   665,500  $7.41 
Schedule of Nonvested Share Activity [Table Text Block]

Number of Shares

  

Fair Value per Share

 

Grant Date

 

Vesting Period (Years)

60,412   $4.85 

August 15, 2023

 

One

46,896   6.65 

August 16, 2022

 

One

40,165   7.47 

August 11, 2021

 

One

41,452   5.79 

August 12, 2020

 

Two

Number of Shares

  

Fair Value per Share

 

Grant Date

 

Vesting Date

70,000   $5.27 

March 26, 2024

 

March 26, 2027

26,000   4.77 

August 14, 2023

 

August 14, 2024

40,000   5.85 

March 21, 2023

 

March 21, 2025

25,000   7.98 

June 9, 2021

 

June 9, 2022

10,000   7.60 

February 22, 2021

 

February 22, 2023

20,000   4.92 

June 10, 2020

 

June 10, 2022